Is Raynaud's disease serious?

Primary Raynaud's is generally benign and manageable with lifestyle measures. Secondary Raynaud's, associated with autoimmune diseases like scleroderma, can be more serious and may lead to tissue damage, digital ulcers, and in rare cases, gangrene.

What is the difference between primary and secondary Raynaud's?

Primary Raynaud's occurs without an underlying disease, is milder, and typically begins in teens or twenties. Secondary Raynaud's is associated with autoimmune or connective tissue diseases, tends to be more severe, and often begins after age 30.

Can Raynaud's affect other parts of the body?

While fingers and toes are most commonly affected, Raynaud's can also involve the nose, ears, lips, and nipples. In rare cases, reduced blood flow can affect internal organs, particularly in secondary Raynaud's associated with scleroderma.

CardiovascularICD-10: I73.0Affects 3–5% of the general population; more common in colder climates

Raynaud's Disease

Also known as: Raynaud's Phenomenon, Raynaud's Syndrome

Raynaud's disease is a condition in which smaller arteries that supply blood to the skin constrict excessively (vasospasm) in response to cold temperatures or emotional stress, limiting blood circulation to the fingers and toes. The affected areas turn white, then blue, then red as blood flow returns. Primary Raynaud's occurs on its own, while secondary Raynaud's is associated with underlying autoimmune or connective tissue diseases and can be more severe.

Symptoms

Cold fingers or toes

Color changes in the skin: white (pallor) → blue (cyanosis) → red (hyperemia)

Numbness and tingling during episodes

Throbbing or stinging pain as blood flow returns

In severe cases: skin ulcers or sores on fingertips

Episodes typically lasting 15–20 minutes

Causes

Excessive vasospasm of digital arteries in response to cold or stress
Primary Raynaud's: cause unknown, no underlying disease
Secondary Raynaud's: associated with scleroderma, lupus, rheumatoid arthritis, or Sjögren syndrome
Occupational factors: vibrating tools (vibration white finger), repetitive hand use

Risk Factors

Female sex (primary Raynaud's is much more common in women)
Age 15–30 for primary Raynaud's
Living in cold climates
Family history of Raynaud's
Connective tissue diseases (for secondary Raynaud's)
Smoking

Diagnosis

Clinical history of characteristic color changes in response to cold or stress
Nailfold capillaroscopy to distinguish primary from secondary Raynaud's
Blood tests: ANA, ESR, CRP, anti-centromere and anti-Scl-70 antibodies
Cold stimulation test (provocation test)

Treatment

Avoiding cold exposure and keeping the whole body warm
Calcium channel blockers (nifedipine, amlodipine) for frequent or severe attacks
Topical nitroglycerin for digital ischemia
Phosphodiesterase-5 inhibitors (sildenafil) for refractory cases
Treatment of underlying autoimmune disease in secondary Raynaud's
Botox injections to digital arteries (emerging therapy)

Prevention

Wear gloves, warm socks, and layered clothing in cold weather
Avoid handling cold objects with bare hands
Quit smoking (nicotine constricts blood vessels)
Manage stress through relaxation techniques
Avoid medications that cause vasoconstriction (certain decongestants, beta-blockers)

When to See a Doctor

Raynaud's episodes accompanied by skin ulcers or sores on fingers
New onset of Raynaud's symptoms after age 30 (suggests secondary cause)
Symptoms associated with joint pain, skin changes, or other systemic complaints
Episodes that are severe, frequent, or worsening

Frequently Asked Questions

Related Conditions

Lupus

Autoimmune

Scleroderma

Autoimmune

Rheumatoid Arthritis

Autoimmune

Peripheral Artery Disease

Cardiovascular

Have questions about Raynaud's Disease?

Ask Mother Nature AI for personalized, evidence-based guidance.

Ask about Raynaud's Disease

Medical Disclaimer: This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider.

Content reviewed against peer-reviewed medical literature and clinical guidelines. Read our editorial standards.